Collaboration Between Clinical Physicians and Public Health Teams in Managing Infectious Disease Outbreaks
DOI:
https://doi.org/10.22399/ijcesen.4093Keywords:
Collaboration, Clinical Physicians, Public Health Teams, Infectious Disease Outbreaks, Early Detection, SurveillanceAbstract
Effective management of infectious disease outbreaks requires seamless collaboration between clinical physicians and public health teams. Clinical physicians play a crucial role in the early detection and diagnosis of infectious diseases, serving as the front-line responders who interact directly with patients. Their observations and clinical data are vital for identifying emerging health threats. By sharing patient information and outbreak patterns with public health teams, clinical physicians can help ensure that public health surveillance systems are alert to new developments. In turn, public health teams provide clinicians with essential guidance and resources, including treatment protocols, vaccination campaigns, and public health advisories, thus creating a two-way communication system vital for timely and effective response strategies. Furthermore, collaboration between these two entities is essential for implementing preventive measures and crafting community-wide interventions. Public health teams rely on data from clinical physicians to establish epidemiological trends and assess the impact of outbreaks on the healthcare system. This collaboration also enables targeted educational efforts aimed at healthcare providers and the public, promoting best practices for infection control and prevention. Additionally, joint training sessions and emergency preparedness drills can arm both clinical physicians and public health officials with the tools needed to respond swiftly and effectively to outbreaks. The synergy between clinical practice and public health not only enhances the immediate response but also contributes to long-term strategies that build resilience against future infectious disease threats.
References
1. Jones J, Hunter D. Consensus Methods for Medical and Health Services Research. British Medical Journal. 1995;311(7001):376-80.
2. Martin-Misener R, Valaitis R.K. A Scoping Literature Review of Collaboration between Primary Care and Public Health. A Report to the Canadian Health Services Research Foundation. Hamilton, ON: School of Nursing, McMaster University; 2008.
3. Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316:171-81.
4. McQuillen DP, MacIntyre AT. The value that infectious diseases physicians bring to the healthcare system. J Infect Dis. 2017;216:588-93.
5. Valaitis R.K., Ehrich A., O'Mara L.M., Brauer P.M. An Environmental Scan of Primary Care and Public Health in the Province of Ontario: A Series Report. Hamilton, ON: McMaster University School of Nursing; 2009.
6. Masotti P, Green M, McColl M.A. Adverse Events in Community Care: Implications for Practice, Policy and Research. Healthcare Quarterly. 2009;12(1):69-76.
7. Goldstein EJC, Petrak RM, Sexton DJ, et al. The value of an infectious diseases specialist. Clin Infect Dis. 2003;36:1013-7.
8. Yeager VA, Beitsch LM, Hasbrouck L. A mismatch between the educational pipeline and public health workforce: can it be reconciled? Public Health Rep. 2016;131:507-9.
9. Lloyd-Jones G., Fowell S., Bligh J. The Use of the Nominal Group Technique as an Evaluative Tool in Medical Undergraduate Education. Medical Education. 1999;33(1):8-13.
10. Rimawi RH, Mazer MA, Siraj DS, Gooch M, Cook PP. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med. 2013;41:2099-107.
11. Beck AJ, Boulton ML, Coronado F. Enumeration of the governmental public health workforce, 2014. Am J Prev Med. 2014;47:S306-13.
12. Burnham JP, Olsen MA, Stwalley D, et al. Infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections. Open Forum Infect Dis. 2018;5.
13. Nowak MA, Nelson RE, Breidenbach JL, Thompson PA, Carson PJ. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am J Health Syst Pharm. 2012;69:1500-8.
14. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173:2039-46.
15. Shih CP, Lin YC, Chan YY, Hsu KH. Employing infectious disease physicians affects clinical and economic outcomes in regional hospitals: evidence from a population-based study. J Microbiol Immunol Infect. 2014;47:297-303.
16. Wendorf KA, Kay M, Baliga C, et al. Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak. Infect Control Hosp Epidemiol. 2015;36:634-42.
17. Peters PJ, Pontones P, Hoover KW, et al. HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. N Engl J Med. 2016;375:229-39.
18. Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010;123:631-7.
19. Schmitt S, McQuillen DP, Nahass R, et al. Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Clin Infect Dis. 2014;58:22-8.
20. Aldeyab MA, Kearney MP, Scott MG, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother. 2012;67:2988-96.
21. Ostrowsky B, Banerjee R, Bonomo RA, et al. Infectious diseases physicians: leading the way in antimicrobial stewardship. Clin Infect Dis. 2018;66:995-1003.
22. McQuillen DP, Petrak RM, Wasserman RB, Nahass RG, Scull JA, Martinelli LP. The value of infectious diseases specialists: non-patient care activities. Clin Infect Dis. 2008;47:1051-63.
23. Rowan M, Hogg W, Huston P. Integrating Public Health and Primary Care. Healthcare Policy. 2007;3(1):160-81.
24. Measles outbreak–California, December 2014-February 2015. MMWR Morb Mortal Wkly Rep. 2015;64:153-4.
25. Measles outbreak–Minnesota April-May 2017. MMWR Morb Mortal Wkly Rep. 2017;66:713-7.
26. Naylor D, Basrur S, Bergeron M.G., Brunham R.C., Butler-Jones D., Dafoe G., et al. Learning from SARS – Renewal of Public Health in Canada. Ottawa: Public Health Agency of Canada; 2003.
27. Walker D, Keon W, Laupacis A, Low D, Moore K, Kitts J., et al. For the Public's Health. Final Report of the Ontario Expert Panel on SARS and Infectious Disease Control. Toronto, Ontario; 2003.
28. Ontario Medical Association (OMA). Primary Care Models Comparison Chart. Toronto: Author; 2008.
29. A national strategy for the elimination of hepatitis B and C: phase two report. Washington, D.C.; 2017.
30. Perth District Health Unit. Enhancing Disease Prevention and Health Promotion in Ontario's Family Health Teams: The Public Health/Primary Health Connection – A Discussion Paper. May 2006.
31. Omojuyigbe J.O., Oladipo H.J., Adegbite M.A., Babatunde Y., Sokunbi T.O., Adedeji O., et al. Current Trends of Lassa fever amidst COVID-19 Pandemic in Nigeria. Global Biosecurity. 2023 Feb;24:5.
32. Amzat J., Aminu K., Kolo V.I., Akinyele A.A., Ogundairo J.A., Danjibo M.C. Coronavirus outbreak in Nigeria: Burden and socio-medical response during the first 100 days. Int J Infect Dis. 2020 Sep;98:218–224. doi: 10.1016/j.ijid.2020.06.067.
33. Nigeria Centre for Disease Control and Prevention. Lassa Fever Weekly Situation Report. 2019.
34. Ibrahim Z., Konlan K.D., Moonsoo Y., Kwetishe P., Ryu J., Da Sol Ro, et al. Influence of Basic Health Care Provision Fund in improving primary Health Care in Kano state, a descriptive cross-sectional study. BMC Health Serv Res. 2023 doi: 10.1186/s12913-023-09708-w.
35. Sokunbi T.O., Omojuyigbe J.O. Need for sustainable health policies toward curbing future pandemics in Africa. Ann Med Surgery. 2022 Oct;82 doi: 10.1016/j.amsu.2022.104506.
36. Kassa M.D., Grace J.M. Race against death or starvation? COVID-19 and its impact on African populations. Public Health Rev. 2020 Dec;41(1) doi: 10.1186/s40985-020-00139-0.
37. Nigeria Can Seize the Opportunity to Realize Its Growth Potential. World Bank.
38. Nwobodo E, Ukwuije F, Egwuatu U, Ezugwu F, Nwobodo N, Ojiajor A, et al. Assessment of the Progress of the Implementation of the Basic Health Care Provision Fund in South East States of Nigeria. Tropical J Med Res. 2022 Jul 30;21(1):75–85.
39. Alawode G., Adewoyin A.B., Abdulsalam A.O., Ilika F., Chukwu C., Mohammed Z., et al. The Political Economy of the Design of the Basic Health Care Provision Fund (BHCPF) in Nigeria: A Retrospective Analysis for Prospective Action. Health Syst Reform. 2022 doi: 10.1080/23288604.2022.2124601.
40. Omojuyigbe JO, Sokunbi TO, Ogodo EC. Multiple crises: Anthrax outbreak amidst Lassa fever and diphtheria endemicity in Nigeria. Journal of Medicine, Surgery, and Public Health. 2023 Jan 1; 1: 100021.
41. Nigeria Centre for Disease Control and Prevention. Official statement following the first reported confirmed case of diphtheria in FCT, Abuja.
42. Connolly MA, Heymann DL. Deadly comrades: war and infectious diseases. Lancet. 2002;360(Suppl):23–24. doi: 10.1016/s0140-6736(02)11807-1.
43. Christian KA, Ijaz K, Dowell SF, Chow CC, Chitale RA, Bresee JS. What we are watching-five top global infectious disease threats, 2012: a perspective from CDC's Global Disease Detection Operations Center. Emerg Health Threats J. 2013;6:20632. doi: 10.3402/ehtj.v6i0.20632.
44. Babaie J, Ardalan A, Vatandoost H, Goya MM, Akbarisari A. Performance assessment of communicable disease surveillance in disasters: a systematic review. PLoS Curr. 2015:7. doi: 10.1371/currents.dis.c72864d9c7ee99ff8fbe9ea707fe4465.
45. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Health Care Infection Control Practices Advisory Committee 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control. 2007;35(10 Suppl 2):65–164. doi: 10.1016/j.ajic.2007.10.007.
46. Harvey PA, Reed RA. Planning environmental sanitation programmes in emergencies. Disasters. 2005;29:129–151. doi: 10.1111/j.0361-3666.2005.00277.x.
47. Liang SY, Theodoro DL, Schuur JD, Marschall J. Infection prevention in the emergency department. Ann Emerg Med. 2014;64:299–313. doi: 10.1016/j.annemergmed.2014.02.024.
48. Behrman AJ, Shofer FS. Tuberculosis exposure and control in an urban emergency department. Ann Emerg Med. 1998;31:370–375. doi: 10.1016/s0196-0644(98)70349-x.
49. Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC) Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2011;60:1–45.
50. Levine AC, Shetty PP, Burbach R, Cheemalapati S, Glavis-Bloom J, Wiskel T. Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease. Ann Emerg Med. 2015;66:285–293. doi: 10.1016/j.annemergmed.2015.03.011.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
